NOT-DA-17-027: Notice of NIDA's Participation in PAR-17-234 " Mechanisms and Consequences of Sleep Disparities in the U.S. (R01)"

Notice of NIDA's Participation in PAR-17-234 "Mechanisms and Consequences of Sleep Disparities in the U.S. (R01)"

Notice Number: NOT-DA-17-027

Key Dates
Release Date: April 24, 2017

Related Announcements
PAR-17-234

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute on Drug Abuse, will participate effective immediately, in PAR-17-234 “Mechanisms and Consequences of Sleep Disparities in the U.S. (R01)".

The following sections have been updated to reflect the participation of NIDA in this PAR:
Part 1. Overview Information
Components of Participating Organizations
National Institute on Drug Abuse (NIDA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.279

Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
Specific Areas of Research Interest
The National Institute on Drug Abuse is particularly interested in:
Sleep and circadian rhythms involve the same neurosystems that affect reward. Drugs of abuse directly affect the quality of sleep in dependent and addicted individuals but also in abstinent individuals even after withdrawal symptoms have subsided. The effects of these drugs vary among various racial and ethnic minorities. Accordingly, more research is needed to explore links between the neurobiology underlying risk for and abuse of psychoactive drugs and sleep deficiencies resulting in health disparities among racial and ethnic minorities.

Some research topics include but are not limited to:

Determination of the contributions of the effects of different drugs of abuse on sleep quality in minority populations.
Investigations on the mechanisms of persistent sleep problems after withdrawal from drugs.
Understanding the effects of prenatal drug exposure on development of sleep patterns in minority populations.

Part 2. Section VII. Agency Contacts
Scientific/Research Contact(s)
Harold Gordon
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504
Email: [email protected]

Financial/Grants Management Contact(s)
Ericka Wells
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6705
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Harold Gordon
National Institute on Drug Abuse (NIDA)
Telephone: 301.443.6504
Email: [email protected]